Pieter Spee
Directeur Technique/Scientifique/R&D chez PURE BIOLOGICS S.A.
Profil
Pieter Spee is currently the Chief Scientific Officer at Pure Biologics SA since 2023.
Prior to this, he worked as the Scientific Director-Translational Immunology at Novo Nordisk A, Chief Scientific Officer at TikoMed AB, and Chief Technology Officer at FibroTx OÜ.
He obtained his doctorate degree from the University of Leiden in 1996.
Postes actifs de Pieter Spee
Sociétés | Poste | Début |
---|---|---|
PURE BIOLOGICS S.A. | Directeur Technique/Scientifique/R&D | 26/05/2023 |
Anciens postes connus de Pieter Spee
Sociétés | Poste | Fin |
---|---|---|
FibroTx OÜ | Directeur Technique/Scientifique/R&D | - |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Directeur Technique/Scientifique/R&D | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formation de Pieter Spee
University of Leiden | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
PURE BIOLOGICS S.A. | Health Technology |
NOVO NORDISK A/S | Health Technology |
Entreprise privées | 2 |
---|---|
FibroTx OÜ | |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Health Technology |